Acute Myeloid Leukaemia News and Research

RSS
Acute Myeloid Leukemia (AML) is a rapidly progressing cancer of the blood characterized by the uncontrolled proliferation of immature blast cells in the bone marrow. The Leukemia and Lymphoma Society estimates that over 13,000 new cases of AML were diagnosed and approximately 9,000 deaths from AML occurred in the U.S. during 2007. AML is generally a disease of older adults, and the median age of a patient diagnosed with AML is about 67 years. A majority of elderly patients are not considered candidates for standard induction therapy or decline therapy, resulting in an acute need for new treatment options.
Combination of epigenetic and immune-based treatments could lead to better blood cancer therapies

Combination of epigenetic and immune-based treatments could lead to better blood cancer therapies

Knowledge bank approach could help find best treatment option for AML patients

Knowledge bank approach could help find best treatment option for AML patients

OGT introduces three new Cytocell Aquarius FISH probes

OGT introduces three new Cytocell Aquarius FISH probes

ATR inhibitors show improved survival and effectiveness in animal models of cancer

ATR inhibitors show improved survival and effectiveness in animal models of cancer

Adolescents and young adults have lower cancer survival rates compared to children

Adolescents and young adults have lower cancer survival rates compared to children

Mitoxantrone for MS linked to colorectal cancer risk

Mitoxantrone for MS linked to colorectal cancer risk

Researchers uncover new clue that may help fight AML

Researchers uncover new clue that may help fight AML

New combination treatment shows promise for treating acute myeloid leukaemia

New combination treatment shows promise for treating acute myeloid leukaemia

Discovery could lead to new leukaemia therapies

Discovery could lead to new leukaemia therapies

Simple blood test could predict relapse in AML patients

Simple blood test could predict relapse in AML patients

Hhex protein could be key target for new therapies to cure leukaemia

Hhex protein could be key target for new therapies to cure leukaemia

Drugs that block KDM4C and PRMT1 genes could be effective in treating AML

Drugs that block KDM4C and PRMT1 genes could be effective in treating AML

Researchers identify genes that act as brakes to stop development of aggressive type of leukaemia

Researchers identify genes that act as brakes to stop development of aggressive type of leukaemia

How important is a mother’s diet before pregnancy? An interview with Dr Matt Silver

How important is a mother’s diet before pregnancy? An interview with Dr Matt Silver

Scientists create first 3-D image of key protein involved in development of cancers

Scientists create first 3-D image of key protein involved in development of cancers

Arsenic trioxide feasible in low-, high-risk acute promyelocytic leukaemia

Arsenic trioxide feasible in low-, high-risk acute promyelocytic leukaemia

BGB324 shows enhanced tumour clearance in mouse carcinoma models

BGB324 shows enhanced tumour clearance in mouse carcinoma models

Scientists identify a gene that can cause more aggressive cancer in AML patients

Scientists identify a gene that can cause more aggressive cancer in AML patients

Hedgehog blockade promising in myeloid malignancies

Hedgehog blockade promising in myeloid malignancies

Researchers identify gene variant that makes breast cancer cells more aggressive

Researchers identify gene variant that makes breast cancer cells more aggressive